US Business

Unilever said it continued to expect sales to grow 3% to 5% this year, with a modest improvement in operating margin, as volumes and price dynamics normalize.

STMicroelectronics lowered its full-year sales guidance after posting first-quarter revenue below forecast, as the demand for chips in the automotive sector slowed.

Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.

Posco said higher raw material prices weighed on earnings amid a slowdown in the industry, though increased steel product prices cushioned the fall in its operating profit.

Barclays confirmed its 2024 forecasts after it reported better-than-expected profits and income for the first quarter.

Buyout firm Affinity Equity Partners’ has started the process to sell the 600-bed Island Hospital with the first bids expected mid-June.

Pickup trucks and resilient consumer spending powered GM’s 24% increase in quarterly profit, but China remains a trouble spot.

JD Sports is buying Hibbett in a deal that values the American retailer at $1.1 billion, doubling down on its push into the U.S. at a challenging time for the sports-retail market.

Novartis lifted its full-year guidance after first-quarter profit and sales rose and beat consensus expectations, boosted by strong sales of key drugs.

Nidec Corp. reported a fourth-quarter net loss on restructuring expenses for its electric-vehicle traction motor business as severe competition disrupts the EV market in China.